ASMB
ASMB clinical trials: ASSEMBLY BIOSCIENCES, INC.
Every trial on ClinicalTrials.gov where ASSEMBLY BIOSCIENCES, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 23
- Trials linked
- 23
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ASMB on the catalyst calendar · ASMB registry changes
- Primary completion Apr 2027Sponsor estimatePhase 1NCT07850999A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Participants With Mild Hepatic Impairment Compared With...Assembly Biosciences · Mild Hepatic ImparementNot yet recruitingASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 2NCT07762027A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionAssembly Biosciences · Chronic Hepatitis D InfectionNot yet recruitingASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 3, 2026ActualPhase 1NCT06385327A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive...Assembly Biosciences · Recurrent Genital Herpes Simplex Type 2CompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 19, 2026ActualPhase 1NCT06698575A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2...Assembly Biosciences · Recurrent Genital Herpes Simplex Type 2CompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 8, 2025ActualPhase 1NCT06740474A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy ParticipantsAssembly Biosciences · Hepatitis Delta VirusCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 15, 2025ActualPhase 1NCT06384131A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus InfectionAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 30, 2023ActualPhase 2NCT04820686A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B InfectionAssembly Biosciences · Chronic Hepatitis BTerminatedASMBLeadABUSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2, 2022ActualPhase 2NCT04781647A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionAssembly Biosciences · Chronic Hepatitis BTerminatedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 12, 2023ActualPhase 1NCT05569941A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy SubjectsAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 24, 2023ActualPhase 1NCT05414981A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus InfectionAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 26, 2021ActualPhase 2NCT03780543A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B PatientsAssembly Biosciences · Chronic Hepatitis BTerminatedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 8, 2021ActualPhase 2NCT04454567A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse...Assembly Biosciences · Chronic Hepatitis BTerminatedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 14, 2021ActualPhase 2NCT04398134A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus InfectionAssembly Biosciences · Chronic Hepatitis BTerminatedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 20, 2021ActualPhase 1NCT03923478ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative ColitisAssembly Biosciences · Ulcerative Colitis Chronic MildTerminatedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 5, 2019ActualPhase 2NCT03576066A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B InfectionAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 3, 2020ActualPhase 1NCT04271592A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy AdultsAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 23, 2020ActualPhase 1NCT03714152A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis BAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 22, 2020ActualPhase 1NCT04637139A Study to Evaluate the Mass Balance Absorption and AME of VBRAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 21, 2019ActualPhase 2NCT03577171A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic...Assembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 12, 2020ActualPhase 1NCT04142762A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy AdultsAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 5, 2019ActualPhase 1NCT04083716A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy AdultsAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2018ActualPhase 1NCT02908191A Study in Healthy Volunteers and Patients With Chronic Hepatitis BAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2018ActualPhase 1/Phase 2NCT03109730Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis BAssembly Biosciences · Chronic Hepatitis BCompletedASMBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 23 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner